Fresenius will rapidly gain scale in North American injectables division, chairman says.
Haights Cross, the seller of Oakstone Publishing, said it was abandoning its sale efforts of other assets alongside the sales announcement.
The company is making room on its board for three nominees from Oliver Press Partners, and analysts anticipate a deal could follow.
Deal, worth about $6.7 billion, anticipated to double Invitrogens consumables business.
CIT Healthcare provided an undisclosed amount of senior debt for the roughly $100 million acquisition.
American Securities Capital Partners agreed to sell a controlling stake in healthcare research firm Press Ganey Associates to private equity firm Vestar Capital Partners.
CCMP Capital Advisors and the Canada Pension Plan Investment Board have launched a new investment play in the hospital sector.
Nabi Biopharmaceuticals could sell for a price in the $300 million to $550 million range, analysts said last week.
Whether or not pharmaceuticals giant Teva Pharmaceutical Industries succeeds in selling its animal health unit, veterinary diagnostics company VCA Antech will not be buying.
Angelo, Gordon has completed the acquisition of National Home Health Care, a provider of home health care and staffing services in the Northeast.